Merck & Co., Inc. (NYSE:MRK) Downgraded by TD Cowen to Hold
Merck & Co., Inc. (NYSE:MRK – Get Free Report) was downgraded by equities research analysts at TD Cowen from a “buy” rating to a “hold” rating in a research report issued on Monday, MarketBeat Ratings reports. They currently have a $100.00 price objective on the stock, down from their prior price objective of $121.00. TD […]
Merck & Co., Inc. (NYSE:MRK – Get Free Report) was downgraded by equities research analysts at TD Cowen from a “buy” rating to a “hold” rating in a research report issued on Monday, MarketBeat Ratings reports. They currently have a $100.00 price objective on the stock, down from their prior price objective of $121.00. TD […]
